EMBO Molecular Medicine to publish under open access model

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO has announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program. Articles in the journal will be open access and free to view, download and share for non-commercial use